Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

The FDA errs on the side of caution when promising approval if the SPA is used and the endpoints are met. So they require a large patient number, long study times, randomization, blinding, etc. That is my understanding. The flip side is, there is no risk of doing a study that the FDA later says was not sufficient to permit approval.